Figure 2
From: An effective strategy to prevent allopurinol-induced hypersensitivity by HLA typing
Flowchart of study design. Among a total of 425 patients with chronic renal insufficiency, 401 patients completed the study, and none of them experienced severe cutaneous adverse reactions (SCARs). *Withdrawal of allopurinol regardless of hypersensitivity.
